Habitual sleep quality, plasma metabolites and risk of coronary heart disease in post-menopausal women

International Journal of Epidemiology

Volumn 48, Issue 4, 2019, Pages 1262-1274

  Huang, Tianyi ^a,b   Zeleznik, Oana A ^a   Poole, Elizabeth M ^a   Clish, Clary B ^c   Deik, Amy A ^c   Scott, Justin M ^c   Vetter, Céline ^d   Schernhammer, Eva S ^a,e   Brunner, Robert ^f   Hale, Lauren ^g   Manson, JoAnn E ^h   Hu, Frank B ^a,b   Redline, Susan ^h   Tworoger, Shelley S ^b,i   Rexrode, Kathryn M ^h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^g Stony Brook Medicine   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

coronary heart disease; epidemiology; metabolomics; sleep; women

Indexed keywords

BETAINE; BILIVERDIN; C REACTIVE PROTEIN; DIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; SERINE; TRIACYLGLYCEROL; TRYPTOPHAN; VALINE; LIPID;

BODY MASS; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; HEALTH RISK; METABOLISM; RISK FACTOR; SECONDARY METABOLITE; SLEEP; WOMENS HEALTH;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HISTONE ACETYLATION; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; METABOLOMICS; MIDDLE AGED; PHYSICAL ACTIVITY; PITTSBURGH SLEEP QUALITY INDEX; POSTMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; SELF REPORT; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; INSOMNIA; LIPIDOMICS; LIQUID CHROMATOGRAPHY; METABOLISM; MULTIVARIATE ANALYSIS; PHYSIOLOGY; RISK FACTOR; SLEEP; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; LIPIDOMICS; LIPIDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; RISK FACTORS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 85065390735     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyy234     Document Type: Article

References (53)

1. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89: 157-61.
2. Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009; 6: 532-42.
3. Regensteiner JG, Golden S, Huebschmann AG. Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation 2015; 132: 2424-47.
4. Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775, 385 individuals and 12, 539 strokes. Lancet 2014; 383: 1973-80.
5. Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep 2006; 29: 85-93.
6. Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 2014; 21: 57-64.
7. Li M, Zhang XW, Hou WS, Tang ZY. Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol 2014; 176: 1044-47.
8. Suarez EC. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 2008; 22: 960-68.
9. Miller MA, Kandala NB, Kivimaki M et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 2009; 32: 857-64.
10. Davies SK, Ang JE, Revell VL et al. Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci USA 2014; 111: 10761-66.
11. Weljie AM, Meerlo P, Goel N et al. Oxalic acid and diacylglycerol 36: 3 are cross-species markers of sleep debt. Proc Natl Acad Sci USA 2015; 112: 2569-74.
12. Chua EC, Shui G, Cazenave-Gassiot A, Wenk MR, Gooley JJ. Changes in plasma lipids during exposure to total sleep deprivation. Sleep 2015; 38: 1683-91.
13. Anderson GL, Manson J, Wallace R et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003; 13: S5-17.
14. Paynter NP, Balasubramanian R, Giulianini F et al. Metabolic predictors of incident coronary heart disease in women. Circulation 2018; 137: 841-53.
15. Huang T, Poole EM, Vetter C et al. Habitual sleep quality and diurnal rhythms of salivary cortisol and dehydroepiandrosterone in postmenopausal women. Psychoneuroendocrinology 2017; 84: 172-80.
16. Luo J, Sands M, Wactawski-Wende J, Song Y, Margolis KL. Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative. Am J Epidemiol 2013; 177: 42-49.
17. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
18. Levine DW, Kripke DF, KaplanRMet al. Reliability and validity of the Women's Health Initiative insomnia rating scale. Psychol Assess 2003; 15: 137-48.
19. Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev 2016; 25: 52-73.
20. Mascanfroni ID, Takenaka MC, Yeste A et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat Med 2015; 21: 638-46.
21. Townsend MK, Clish CB, Kraft P et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem 2013; 59: 1657-67.
22. Storey JD. A direct approach to false discovery rates. J R Stat Soc B Stat Methodol 2002; 64: 479-98.
23. Efron B, Hastie T, Johnstone I, Tibshirani R. Least angle regression. Ann Stat 2004; 32: 407-99.
24. Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: Theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 2013; 18: 137-50.
25. Xiao Q, Derkach A, Moore SC et al. Habitual sleep and human plasma metabolomics. Metabolomics 2017; 13: 63.
26. Aho V, Ollila HM, Kronholm E et al. Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses. Sci Rep 2016; 6: 24828.
27. Buysse DJ. Sleep health: can we define it? Does it matter? Sleep 2014; 37: 9-17.
28. Bertisch SM, Pollock BD, Mittleman MA et al. Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study. Sleep 2018; 41. doi: 10. 1093/sleep/zsy047.
29. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care 2009; 32: 1980-85.
30. Stegemann C, Pechlaner R, Willeit P et al. Lipidomics profiling and risk of cardiovascular disease in the prospective populationbased Bruneck study. Circulation 2014; 129: 1821-31.
31. Rhee EP, Cheng S, Larson MG et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011; 121: 1402-11.
32. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349-52.
33. Rice JC, Allis CD. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr Opin Cell Biol 2001; 13: 263-73.
34. Hebbes TR, Thorne AW, Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 1988; 7: 1395-402.
35. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006; 125: 497-508.
36. Feng D, Liu T, Sun Z et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011; 331: 1315-19.
37. Nilsson EK, Bostrom AE, Mwinyi J, Schioth HB. Epigenomics of total acute sleep deprivation in relation to genome-wide DNA methylation profiles and RNA expression. OMICS 2016; 20: 334-42.
38. Ordová s JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010; 7: 510-19.
39. Detopoulou P, Panagiotakos DB, Antonopoulou S, Pitsavos C, Stefanadis C. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: The ATTICA study. Am J Clin Nutr 2008; 87: 424-30.
40. Konstantinova SV, Tell GS, Vollset SE, Nygård O, Bleie Ø, Ueland PM. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 2008; 138: 914-20.
41. Ejaz A, Martinez-Guino L, Goldfine AB et al. Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice. Diabetes 2016; 65: 902-12.
42. Walford GA, Ma Y, Clish C, Florez JC, Wang TJ, Gerszten RE. Metabolite profiles of diabetes incidence and intervention response in the diabetes prevention program. Diabetes 2016; 65: 1424-33.
43. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-46.
44. Stocker R, McDonagh AF, Glazer AN, Ames BN. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol 1990; 186: 301-09.
45. Kunutsor SK, Bakker SJ, Gansevoort RT, Chowdhury R, Dullaart RP. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler Thromb Vasc Biol 2015; 35: 716-24.
46. Abbasi A, Deetman PE, Corpeleijn E et al. Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes 2015; 64: 1459-69.
47. Wang L, Bautista LE. Serum bilirubin and the risk of hypertension. Int J Epidemiol 2015; 44: 142-52.
48. Kahn M, Sheppes G, Sadeh A. Sleep and emotions: bidirectional links and underlying mechanisms. Int J Psychophysiol 2013; 89: 218-28.
49. Vgontzas AN, Bixler EO, Basta M. Obesity and sleep: a bidirectional association? Sleep 2010; 33: 573-74.
50. Huang T, Lin BM, Stampfer MJ, Tworoger SS, Hu FB, Redline S. A population-based study of the bidirectional association between obstructive sleep apnea and type 2 diabetes in three prospective U. S. cohorts. Diabetes Care 2018; 41: 2111-9.
51. Campos-Rodriguez F, Gonzalez-Martinez M, Sanchez-Armengol A et al. Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea. Eur Respir J 2017; 50. doi: 10. 1183/13993003. 00257-2017.
52. Xu H, Zheng X, Qian Y et al. Metabolomics profiling for obstructive sleep apnea and simple snorers. Sci Rep 2016; 6: 30958.
53. Ferrarini A, Ruperez FJ, Erazo M et al. Fingerprinting-based metabolomic approach with LC-MS to sleep apnea and hypopnea syndrome: a pilot study. Electrophoresis 2013; 34: 2873-81.